研發(fā)與技術(shù)
R&D and Technology
-
查看詳情 >
2023-A Phase Ib study of anti-EGFR antibody SCT200 in combination with anti-PD-1 antibody SCT-I10A for patients with RASBRAF wild-type static colorectal cancer
Colorectal cancer (CRC) is one of the most prevalent malignancies ...
2023-12-23 -
查看詳情 >
Efficacy Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (Omfiloctocog alfa) in Previously Treated Children with Severe Hemophilia A.
2022 - Omfiloctocog alfa the first China-developed recombinant fac...
2022-08-30 -
查看詳情 >
Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae
2022 - The ongoing COVID-19 pandemic caused by SARS-CoV-2 has led ...
2022-08-30 -
查看詳情 >
Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
2022 - A new virus‐like particle d vaccine covering 14 types of hi...
2022-08-30 -
查看詳情 >
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022 - Monoclonal antibodies represent important weapons in our ar...
2022-08-30 -
查看詳情 >
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second line therapy in advanced esophageal squamous cell cancer
2022 - The mainstay treatment of esophageal squamous cell carcinom...
2022-08-30 -
查看詳情 >
基于免疫球蛋白G降解酶切和高效液相色譜的抗體電荷異構(gòu)體分析技術(shù)
2021 - 探索和優(yōu)化單克隆抗體電荷異構(gòu)體分析的酶切預(yù)處理和高效液相色譜檢測(cè)方法。 方法：采用和優(yōu)化基于Thermo ProPac...
2022-08-30 -
查看詳情 >
生物藥產(chǎn)業(yè)蓬勃發(fā)展早期的奠基性系統(tǒng)開發(fā)——緬懷王義翹教授的開創(chuàng)性研究和成就
2021 - 以單克隆抗體藥物及重組蛋白為代表的生物藥在腫瘤、自身免疫性疾病、病毒感染等多個(gè)重大疾病的預(yù)防及治療 領(lǐng)域發(fā)揮了重要作...
2021-08-30